首页> 外文OA文献 >Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
【2h】

Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator

机译:尿激酶型纤溶酶原激活物在没有其受体或组织型纤溶酶原激活物的情况下可有效清除纤维蛋白

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The availability of gene-targeted mice deficient in the urokinase-type plasminogen activator (uPA), urokinase receptor (uPAR), tissue-type plasminogen activator (tPA), and plasminogen permits a critical, genetic-based analysis of the physiological and pathological roles of the two mammalian plasminogen activators. We report a comparative study of animals with individual and combined deficits in uPAR and tPA and show that these proteins are complementary fibrinolytic factors in mice. Sinusoidal fibrin deposits are found within the livers of nearly all adult mice examined with a dual deficiency in uPAR and tPA, whereas fibrin deposits are never found in livers collected from animals lacking uPAR and rarely detected in animals lacking tPA alone. This is the first demonstration that uPAR has a physiological role in fibrinolysis. However, uPAR-/-/tPA-/- mice do not develop the pervasive, multi-organ fibrin deposits, severe tissue damage, reduced fertility, and high morbidity and mortality observed in mice with a combined deficiency in tPA and the uPAR ligand, uPA. Furthermore, uPAR-/-/tPA-/- mice do not exhibit the profound impairment in wound repair seen in uPA-/-/tPA-/- mice when they are challenged with a full-thickness skin incision. These results indicate that plasminogen activation focused at the cell surface by uPAR is important in fibrin surveillance in the liver, but that uPA supplies sufficient fibrinolytic potential to clear fibrin deposits from most tissues and support wound healing without the benefit of either uPAR or tPA.
机译:缺乏尿激酶型纤溶酶原激活物(uPA),尿激酶受体(uPAR),组织型纤溶酶原激活物(tPA)和纤溶酶原的基因靶向小鼠的可用性允许对生理和病理学作用进行关键的基于遗传的分析两种哺乳动物纤溶酶原激活剂中的一种。我们报告了对uPAR和tPA中存在个体和联合缺陷的动物的比较研究,结果表明这些蛋白质是小鼠中的纤溶因子的补充。在uPAR和tPA双重缺乏的几乎所有成年小鼠的肝脏中都发现了正弦纤维蛋白沉积物,而从缺乏uPAR的动物收集的肝脏中从未发现过纤维蛋白沉积物,而在仅缺乏tPA的动物中很少发现。这是uPAR在纤维蛋白溶解中具有生理作用的第一个证明。但是,在合并了tPA和uPAR配体缺乏症的小鼠中,uPAR-/-/ tPA-/-小鼠未出现普遍存在的多器官纤维蛋白沉积,严重的组织损伤,生育力降低以及高发病率和死亡率, uPA。此外,当用全厚度皮肤切口攻击时,uPAR-/-/ tPA-/-小鼠并未表现出在uPA-/-/ tPA-/-小鼠中看到的伤口修复的严重损害。这些结果表明,uPAR集中在细胞表面的纤溶酶原激活在肝纤维蛋白监测中很重要,但是uPA提供了足够的纤维蛋白溶解潜能,可以清除大多数组织中的纤维蛋白沉积并支持伤口愈合,而无uPAR或tPA的好处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号